---
$id: https://graph.org.ai/products/commodity/51392216
$type: Product
source: UNSPSC
code: "51392216"
title: "Tramazoline"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tramazoline

**UNSPSC Code**: 51392216
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H17N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SLE31693IV, chemically known as 4,5-dihydro-n-(5,6,7,8-tetrahydro-1-naphthalenyl)-1h-imidazol-2-amine but generally known as tramazoline, which bears US NIH Compound Identifier 5524. European Medicines Agency schedules Tramazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11211MIG. The term TRAMAZOLINE is an International Non-Proprietary Name. World Health Organization schedules tramazoline in its Anatomical Therapeutic Chemical (ATC) Classification. TRAMAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tramazoline under HS 29332990 and SITC 51573. As of Q4 2014, TRAMAZOLINE remains the US FDA Preferred Term for this commodity. Tramazoline bears US NLM identifiers UMLS ID C0076890 and NCI Concept Code C87582. SMILES: N(C1C2CCCCC2CCC1)C1=NCCN1.

